Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene

Details for Australian Patent Application No. 2007241621 (hide)

Owner Academisch Ziekenhuis Leiden

Inventors Den Dunnen, Johannes Theodorus; 'T Hoen, Peter Abraham Christiaan; Sterrenberg, Petronella Johanna Elisabeth; Van Ommen, Garrit-Jan Boudewijn

Agent Davies Collison Cave

Pub. Number AU-B-2007241621

PCT Pub. Number WO2007/123402

Priority PCT/ NL2006/000207 20.04.06 NL

Filing date 20 April 2007

Wipo publication date 1 November 2007

Acceptance publication date 21 April 2011

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C12N 5/077 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2007/123402 Priority application(s): WO2007/123402

21 April 2011 Application Accepted

  Published as AU-B-2007241621

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007241622-Improved treatment of cystic fibrosis

2007241619-Vaccine against nicotine addiction